| Datum | Källa | Rubrik | Typ | Alternativ |
|---|---|---|---|---|
| 2024-06-17 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Elicera teams up with China Medical University for cancer study | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-06-17 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Elicera inleder samarbete med China Medical University för cancerstudie | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-06-11 | Elicera Therapeutics | Elicera Therapeutics enters a preclinical collaboration agreement with China Medical University for the development of ELC-201 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-06-11 | Elicera Therapeutics | Elicera Therapeutics ingår prekliniskt samarbetsavtal med China Medical University för utvecklingen av ELC-201 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-06-07 | Elicera Therapeutics | BioStock: Elicera Therapeutics vd berättar om framtidens immunterapi | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-05-29 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Elicera's first clinical CAR T-Cell study CARMA set to begin | Pressreleaser | Visa Stäng |
|
Pressreleaser |
Elicera Therapeutics: BioStock: Elicera’s first clinical CAR T-Cell study CARMA set to beginRead the article at biostock.se: https://www.biostock.se/en/2024/05/eliceras-first-clinical-car-t-cell-study-carma-set-to-begin/ This is a press release from BioStock – Connecting Innovation & Capital. https://www.biostock.se/ |
||||
| 2024-05-29 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Elicera närmar sig studiestart av sin första kliniska CAR T-cellsstudie CARMA | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-05-28 | Penser Access by Carnegie | Penser Access by Carnegie: Elicera Therapeutics: CARMA-studien inom räckhåll | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-05-27 | Elicera Therapeutics | Elicera Therapeutics AB (publ) Delårsrapport 1 januari - 31 mars 2024 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2024-05-27 | Elicera Therapeutics | Elicera Therapeutics AB (publ) Interim Report 1 January - 31 March 2024 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2024-05-16 | Elicera Therapeutics | Kommuniké från årsstämma i Elicera Therapeutics AB (publ) den 16 maj 2024 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-04-16 | Elicera Therapeutics | Elicera Therapeutics publishes the annual report for 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2024-04-16 | Elicera Therapeutics | Elicera Therapeutics publicerar årsredovisningen för 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2024-04-11 | Elicera Therapeutics | Kallelse till årsstämma i Elicera Therapeutics AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-03-28 | Elicera Therapeutics | Elicera Therapeutics: Nomination committee proposes CMC specialist to Elicera's board of directors | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-03-28 | Elicera Therapeutics | Elicera Therapeutics valberedning föreslår CMC specialist till styrelsen | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-03-25 | Elicera Therapeutics | Elicera Therapeutics meddelar sista dag för handel i BTU och första dag för handel i teckningsoptioner serie TO2 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-03-25 | Elicera Therapeutics | Elicera Therapeutics announces the last day of trading in BTU and the first day of trading in warrants of series TO2 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-03-22 | Elicera Therapeutics | Elicera Therapeutics AB byter Certified Adviser och Likviditetsgarant till Mangold Fondkommission AB | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-03-22 | Elicera Therapeutics | Elicera Therapeutics changes Certified Adviser and Liquidity provider to Mangold Fondkommission AB | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-03-11 | Elicera Therapeutics | Elicera Therapeutics offentliggör utfall i företrädesemissionen | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-03-11 | Elicera Therapeutics | Elicera Therapeutics announces outcome in rights issue | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-03-07 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Elicera collaborates with US cancer centre to evaluate iTANK | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-03-07 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Elicera i samarbete med cancercenter i USA för utvärdering av iTANK | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-03-06 | Elicera Therapeutics | Elicera Therapeutics: Elicera ingår avtal med framstående amerikanskt cancercenter för att utvärdera användningen av iTANK i T-cellsreceptorterapier | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-03-06 | Elicera Therapeutics | Elicera Therapeutics: Elicera enters agreement with prominent US Cancer Center to evaluate the use of iTANK in T-cell receptor therapies | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-03-04 | Elicera Therapeutics | Elicera Therapeutics presenteras på Life Sciencedagen i Göteborg den 6 mars | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-03-04 | Elicera Therapeutics | Elicera Therapeutics erhåller utökade teckningsåtaganden från styrelse och ledning i den pågående företrädesemissionen | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-03-04 | Elicera Therapeutics | Elicera Therapeutics receives additional subscription commitments from the board and management in the ongoing rights issue | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-03-04 | Elicera Therapeutics | Last day of trading in unit rights in Elicera Therapeutics rights issue | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-03-04 | Elicera Therapeutics | Sista dag för handel med uniträtter i Elicera Therapeutics företrädesemission | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-29 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Emission ska ta Eliceras ELC-301 igenom klinisk studie | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-02-27 | Elicera Therapeutics | Elicera Therapeutics: Eliceras vd till BioStock: "Den viktigaste händelsen sedan Eliceras start | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-02-26 | Penser Future by Carnegie | Penser Future by Carnegie: Intervju med Elicera Therapeutics- Carnegie Investment Bank - 26 feb 2024 | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-02-23 | Elicera Therapeutics | The subscription period in Elicera Therapeutics' rights issue of units starts today | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-23 | Elicera Therapeutics | Teckningsperioden i Elicera Therapeutics företrädesemission av units inleds idag | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-21 | Elicera Therapeutics | Elicera Therapeutics offentliggör prospekt i samband med företrädesemission av units | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-21 | Elicera Therapeutics | Elicera Therapeutics publishes prospectus in connection with rights issue of units | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-20 | Elicera Therapeutics | Kommuniké från extra bolagsstämma i Elicera Therapeutics AB (publ) den 20 februari 2024 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-19 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Full fart framåt för Elicera under 2024 | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-02-19 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Full speed ahead for Elicera in 2024 | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-02-16 | Elicera Therapeutics | Elicera Therapeutics abstract om iTANK-plattformens potential att förstärka CAR T-cellbehandling av solida tumörer accepterad för presentation på ISCT 2024 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-16 | Elicera Therapeutics | Elicera Therapeutics' abstract on the iTANK platform's potential to enhance CAR T-cell treatment of solid tumors accepted for presentation at ISCT 2024 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-16 | Elicera Therapeutics | Elicera Therapeutics: Elicera invites to investor meetings on February 28[th] and 29[th] 2024 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-16 | Elicera Therapeutics | Elicera Therapeutics: Elicera bjuder in till investerarträffar 28 och 29 februari 2024 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-14 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Elicera gets green light for CAR T clinical study | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-02-14 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Elicera får grönt ljus för klinisk CAR T-studie | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-02-14 | Penser Future by Carnegie | Penser Future by Carnegie: Elicera Therapeutics - Grönt ljus från Läkemedelsverket | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-02-13 | Elicera Therapeutics | Elicera Therapeutics AB (publ) Bokslutskommuniké 1 januari - 31 december 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-13 | Elicera Therapeutics | Elicera Therapeutics AB (publ) Year-End Report 1 January - 31 December 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-09 | Elicera Therapeutics | Elicera Therapeutics erhåller godkännande att initiera den kliniska fas I/II-studien CARMA med CAR T-cellsterapin ELC-301 i B-cellslymfom | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-09 | Elicera Therapeutics | Elicera Therapeutics receives approval to initiate clinical Phase I/II-study CARMA with CAR T-cell therapy ELC-301 in B-Cell lymphoma | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-01-18 | Elicera Therapeutics | KALLELSE TILL extra bolagsSTÄMMA I Elicera Therapeutics AB | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-01-18 | Elicera Therapeutics | Elicera Therapeutics: NOTICE OF EXTRAORDINARY GENERAL MEETING IN elicera therapeutics AB | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-01-18 | Elicera Therapeutics | Elicera Therapeutics: Eliceras styrelse föreslår en företrädesemission av units om cirka 64 MSEK | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-01-18 | Elicera Therapeutics | Elicera Therapeutics: Elicera's Board of Directors proposes a rights issue of units of approximately SEK 64 million | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-01-17 | Elicera Therapeutics | Elicera Therapeutics medgrundare Magnus Essand inbjuden att presentera bolagets CAR T-cellsprojekt vid världens största konferens om cancerimmunterapi, CICON | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-01-17 | Elicera Therapeutics | Elicera Therapeutics' co-founder Magnus Essand invited to present the company's CAR T-cell projects at the world's largest cancer immunotherapy conference, CICON | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-01-09 | Elicera Therapeutics | Elicera Therapeutics deltar i ett samarbetsprojekt för utveckling av förbättrad CAR T-cellstillverkning som tilldelats forskningsstöd om 850 TSEK | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-01-09 | Elicera Therapeutics | Elicera Therapeutics participates in a collaborative project for the development of improved CAR T-cell production that has been awarded research support of SEK 850 thousand | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-12-22 | Elicera Therapeutics | Elicera Therapeutics medgrundare får anslag på totalt 4,8 MSEK från Barncancerfonden för att stödja CAR T-forskning | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-12-22 | Elicera Therapeutics | Elicera Therapeutics' co-founder receives a grant totalling 4.8 MSEK from the Swedish Childhood Cancer Fund to support CAR T-cell research | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-12-22 | Elicera Therapeutics | Elicera Therapeutics submits GMP validation data to the Swedish Medical Products Agency for the CARMA study to supplement the conditionally approved clinical trial application | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-12-22 | Elicera Therapeutics | Elicera Therapeutics lämnar in GMP-valideringsdata till Läkemedelsverket för CARMA-studien i syfte att komplettera den villkorat godkända kliniska prövningsansökan | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-12-21 | Elicera Therapeutics | Elicera Therapeutics: BioStock: FDA CAR T investigation does not affect Elicera | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-12-21 | Elicera Therapeutics | Elicera Therapeutics: BioStock: FDA:s CAR T-utredning påverkar inte Elicera | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-11-30 | Elicera Therapeutics | Elicera Therapeutics changes Certified Adviser and Liquidity provider to Carnegie Investment Bank AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-11-30 | Elicera Therapeutics | Elicera Therapeutics AB byter Certified Adviser och Likviditetsgarant till Carnegie Investment Bank AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-11-29 | Elicera Therapeutics | Elicera Therapeutics: BioStock: CAR T deal puts spotlight on Elicera's technology | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-11-29 | Elicera Therapeutics | Elicera Therapeutics: BioStock: CAR T-affär sätter fokus på Eliceras teknik | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-11-16 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Eliceras vd: "iTANK har hög potential vid behandling av solida tumörer" | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-11-16 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Elicera's CEO: " iTANK has great potential in treating solid tumours" | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-11-15 | Penser Future | Penser Future: Närmar sig en rad viktiga värdehöjande milstolpar - Elicera Therapeutics | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-11-14 | Elicera Therapeutics | Elicera Therapeutics AB (publ) Delårsrapport 1 januari - 30 september 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-11-14 | Elicera Therapeutics | Elicera Therapeutics AB (publ) Interim Report 1 January - 30 June 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-10-31 | Elicera Therapeutics | Elicera Therapeutics utser valberedning | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-10-31 | Elicera Therapeutics | Elicera Therapeutics: Nomination Committee for Elicera therapeutics appointed | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-10-18 | Elicera Therapeutics | Elicera Therapeutics presenterar på BioStock Life Science Summit den 26 oktober | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-09-08 | Elicera Therapeutics | Elicera Therapeutics får besked om beviljande av kinesiskt patent som skyddar iTANK-plattformen | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-09-08 | Elicera Therapeutics | Elicera Therapeutics receives Notice of Allowance for Chinease patent protecting the iTANK platform | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-08-30 | Penser Future | Penser Future: I väntan på studiestart - Elicera Therapeutics | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-08-29 | Elicera Therapeutics | Elicera Therapeutics AB (publ) Interim Report 1 January - 30 June 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-08-29 | Elicera Therapeutics | Elicera Therapeutics AB (publ) Delårsrapport 1 januari - 30 juni 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-08-15 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Elicera's potential in cancer therapy published in Nature Communications | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-08-15 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Eliceras potential inom cancerterapi publicerad i Nature Communications | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-08-10 | Elicera Therapeutics | Elicera Therapeutics publishes a scientific article in Nature Communications about the CAR T construct in the ELC-401 program | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-08-10 | Elicera Therapeutics | Elicera Therapeutics publicerar en vetenskaplig artikel i Nature Communications om CAR T-konstruktionen i ELC-401 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-07-13 | Elicera Therapeutics | BioStock: Elicera Therapeutics säkrar viktigt EU-patent | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-07-13 | Elicera Therapeutics | BioStock: Elicera Therapeutics receives important EU patent | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-07-11 | Elicera Therapeutics | Elicera Therapeutics får besked om beviljande av europeiskt patent som skyddar iTANK[TM]-plattformen | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-07-11 | Elicera Therapeutics | Elicera Therapeutics receives Notice of Allowance for European patent protecting the iTANK[TM] platform | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-06-30 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Elicera gives an update in Cancer Immunotherapy Month | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-06-30 | Elicera Therapeutics | Elicera Therapeutics: BioStock: Elicera uppdaterar i samband med Cancer Immunotherapy Month | Pressreleaser | Visa Stäng |
|
|
||||
Kommande händelser